Nature, Published online: 13 December 2023; doi:10.1038/d41586-023-03557-7
Current injectable COVID-19 vaccines are unable to induce robust immunity in the mucosal tissues lining the airways. A protein-based vaccine delivered to the lungs in the form of an inhaled dry powder shows promise as a way forward.
Source link